东方中科(002819) - 2023 Q1 - 季度财报

Financial Performance - The net loss for the first quarter was CNY 53,905,786.84, compared to a net loss of CNY 13,796,328.43 in the same period last year, representing an increase in loss of approximately 290.5%[25] - The operating profit showed a loss of CNY 57,139,250.80, worsening from a loss of CNY 13,602,920.55 year-over-year[25] - The net profit attributable to shareholders was -¥33,421,489.70, representing a decrease of 276.45% from -¥8,878,144.75 in the same period last year[31] - The weighted average return on net assets was -1.00%, compared to -0.23% in the previous year[31] - The net loss attributable to the parent company was ¥33,421,489.70, compared to a loss of ¥8,878,144.75 in the previous period, indicating a significant decline in profitability[44] - Basic earnings per share for the current period were -0.1093, worsening from -0.0279 in the previous period[44] Revenue and Costs - The company's operating revenue for Q1 2023 was ¥632,625,421.53, an increase of 9.94% compared to ¥575,407,115.00 in the previous year[31] - Total operating revenue for the current period reached ¥632,625,421.53, an increase of 9.2% compared to ¥575,407,115.00 in the previous period[41] - Total operating costs amounted to ¥697,736,031.27, up 16.7% from ¥597,912,459.48 in the prior period, with operating costs specifically rising from ¥476,350,161.99 to ¥521,346,586.59[41] Assets and Liabilities - Total non-current assets increased by 43.89% to ¥15,463,960.06 compared to the beginning of the period[6] - The total assets decreased from CNY 5,154,039,762.40 to CNY 4,992,804,836.01, a decline of approximately 3.14%[21] - The company's long-term equity investments increased from CNY 3,327,050.35 to CNY 3,976,005.61, reflecting a growth of approximately 19.5%[21] - The total non-current liabilities decreased from CNY 1,220,157,594.86 to CNY 1,111,417,452.70, a reduction of about 8.9%[21] - The company’s total liabilities decreased from CNY 3,017,197,357.54 to CNY 2,933,000,000.00, a decrease of approximately 2.8%[21] - The total liabilities decreased to ¥1,209,353,400.98 from ¥1,319,761,714.24, reflecting a reduction in financial obligations[41] - The total equity attributable to shareholders decreased to ¥3,322,894,791.00 from ¥3,353,237,106.99, indicating a decline in shareholder value[41] Cash Flow - Net cash flow from investment activities surged by 222.04% to ¥73,408,311.15, mainly due to the maturity of financial products[7] - Net cash flow from financing activities improved by 145.81% to ¥23,796,457.93, resulting from increased borrowings[7] - The net cash flow from operating activities was -¥281,978,395.69, a decline of 21.88% compared to -¥231,354,219.53 in the previous year[31] - The company reported a net cash outflow of ¥184,448,922.90 in the current period, compared to an outflow of ¥260,216,174.67 in the previous period, indicating improved cash management[47] - Cash received from operating activities totaled ¥1,308,889,335.25, up from ¥1,007,502,506.51 in the previous year[27] - Cash paid for purchasing goods and services was ¥831,286,617.29, an increase from ¥551,190,470.24 in the previous year[27] - The cash flow from investment activities included cash recovered from investments amounting to ¥168,228,356.16, up from ¥130,000,000.00 in the previous year[27] - The company experienced a decline in cash and cash equivalents, with a balance of ¥1,066,248,282.06 at the end of the reporting period, down from ¥1,274,591,208.39 at the beginning of the year[38] - Cash and cash equivalents at the end of the period were ¥1,048,568,961.33, down from ¥1,267,542,401.09 at the end of the previous period[47] Expenses - Management expenses rose by 81.80% to ¥57,486,308.77, primarily due to the addition of new subsidiaries[6] - R&D expenses increased by 46.72% to ¥56,871,799.61, reflecting a stronger focus on research and development initiatives[6] - Research and development expenses increased to ¥56,871,799.61 from ¥38,763,100.64, highlighting a focus on innovation[41] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 17,166[7] - The largest shareholder, Dongfang Keyi Holdings Group Co., Ltd., holds 24.87% of the shares[7] Other Financial Metrics - Credit impairment losses increased by 136.55% to -¥3,962,618.82, indicating a rise in provisions for credit losses[7] - Asset disposal gains rose significantly by 3532.37% to ¥2,608,327.71, due to increased income from leasing asset disposals[7] - The company reported a significant increase in other comprehensive income, which was not detailed in the provided data, suggesting potential improvements in investment performance[25] - The company’s deferred tax assets increased from CNY 54,427,754.13 to CNY 61,927,962.02, an increase of about 13.8%[21] - The company is focusing on enhancing its investment strategies and exploring new market opportunities, although specific details were not provided in the report[25]